Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of the National Cancer Institute

• Publication date

  1994-04-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/86.7.549PMID 8133539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Genetic Alterations of Chromosome 17 and p53 Nuclear Overexpression in Human Bladder Cancer

  1993cited by this paper
• Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

  1993cited by this paper
• Regulation of the specific DNA binding function of p53.

  1992cited by this paper
• Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancer

  1992cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• Biochemical properties of the growth suppressor/oncoprotein p53.

  1992cited by this paper
• Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.

  1992cited by this paper
• Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

  1992cited by this paper
• Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.

  1992cited by this paper
• Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.

  1992cited by this paper
• Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.

  1992cited by this paper
• Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.

  1992cited by this paper
• Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.

  1991cited by this paper
• Involvement of wild-type p53 protein in the cell cycle requires nuclear localization.

  1991cited by this paper
• Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

  1991cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations.

  1991cited by this paper
• Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.

  1991cited by this paper
• Sarcomas of soft tissue and bone

  1991cited by this paper
• Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.

  1990cited by this paper
• Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.

  1990cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

  1990cited by this paper
• Presence of a potent transcription activating sequence in the p53 protein.

  1990cited by this paper
• Mechanisms of p53 loss in human sarcomas.

  1990cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• The p53 proto-oncogene can act as a suppressor of transformation.

  1989cited by this paper
• Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10

  1989cited by this paper
• Tumor suppressor genes: the puzzle and the promise.

  1989cited by this paper
• Prognostic significance of Ki‐67 reactivity in soft tissue sarcomas

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• The Rb gene and the negative regulation of cell growth.

  1989cited by this paper
• Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

  1988cited by this paper
• Genetics of cancer predisposition.

  1987cited by this paper
• Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

  1986cited by this paper
• Monoclonal antibodies against simian virus 40 nuclear large T tumour antigen: epitope mapping, papova virus cross‐reaction and cell surface staining.

  1984cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

  1983cited by this paper
• Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells

  1981cited by this paper
• T antigen is bound to a host protein in SY40-transformed cells

  1979cited by this paper
• Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

  1979cited by this paper
• A clinical and pathological staging system for soft tissue sarcomas

  1977cited by this paper
• Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

  1969cited by this paper

• Immunohistochemical evaluation of glucose transporter protein-1 in relation to cell proliferation in some soft tissue sarcomas

  2018influential citation
• 3D chick embryo chorioallantoic membrane model as an in vivo model to study morphological and histopathological features of feline fibrosarcomas

  2017cites this paper
• Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

  2016cites this paper
• Sarcomas of Soft Tissue

  2014cites this paper
• Endogenous Human MDM2-C Is Highly Expressed in Human Cancers and Functions as a p53-Independent Growth Activator

  2013cites this paper
• Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas

  2013cites this paper
• Screening E3 Substrates Using a Live Phage Display Library

  2013cites this paper
• Characterization of a Mouse Model of Soft Tissue Sarcoma: Intraoperative Molecular Imaging and miRNA Regulation of Metastasis

  2013cites this paper
• Oncogene‐dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma

  2013cites this paper
• Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.

  2012cites this paper
• Identifying and Targeting Molecular Deregulations in Uterine Leiomyosarcoma: A Role for mTOR Inhibition-Based Combination Therapies

  2012cites this paper
• Attenuation of Soft-Tissue Sarcomas Resistance to the Cytotoxic Action of TNF-α by Restoring p53 Function

  2012cites this paper
• Evaluation of immunohistochemical expression of MDM2 protein in comparison with MDM2 gene amplification in diagnosing lipomatous tumors

  2011cites this paper
• Prognostic Significance of the Alterations of the G1-S Checkpoint in Localized Leiomyosarcoma of the Peripheral Soft Tissue

  2011cites this paper
• P53 Labeling Index as a Prognostic Factor in Adult Soft Tissue Sarcomas – An Analysis of 97 Patients

  2010cites this paper
• Novel Properties of SP cells in STS, and How They May Be Targeted to Develop Potential Therapies

  2010cites this paper
• Genetics of soft tissue tumors

  2010cites this paper
• CHAPTER 46 – Soft Tissues

  2009cites this paper
• A retrospective analysis of radiation therapy for the treatment of feline vaccine-associated sarcoma.

  2009cites this paper
• Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome

  2009cites this paper
• Proliferation and apoptosis of tumour cells before and after neoadjuvant therapy for high‐grade extremity sarcomas: divergent associations with tumour response and prognosis

  2008cites this paper
• Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.

  2008cites this paper
• Intraperitoneal dedifferentiated liposarcoma: a case report.

  2008cites this paper
• Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas.

  2007cites this paper
• p-Phenylenediamine induced DNA damage in SV-40 immortalized human uroepithelial cells and expression of mutant p53 and COX-2 proteins.

  2007cites this paper
• Molecules in Leiomyosarcoma

  2007cites this paper
• Mutation of Cell Cycle Regulators

  2007cites this paper
• Extreme sensitivity to Yondelis® (Trabectedin, ET‐743) in low passaged sarcoma cell lines correlates with mutated p53

  2007cites this paper
• Die Lymphangiogeneseachse beim Harnblasenkarzinom

  2007cites this paper
• [Lymphangiogenesis axis in bladder carcinoma. An analysis with tissue microarray technology].

  2007cites this paper
• Detecção da fusão SS18-SSX em material parafinado e comparação de métodos moleculares como ferramentas no diagnóstico do Sarcoma Sinovial

  2007cites this paper
• Reassessment of the 1993 Osaka grading system for localized soft tissue sarcoma in Japan.

  2006cites this paper
• Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas

  2006cites this paper
• Leiomyosarcoma

  2006cites this paper
• Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.

  2006cites this paper
• Prognostic Significance of Activated AKT Expression in Soft-Tissue Sarcoma

  2006cites this paper
• Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).

  2006cites this paper
• Wild-type p53 Inhibits Nuclear Factor-κB–Induced Matrix Metalloproteinase-9 Promoter Activation: Implications for Soft Tissue Sarcoma Growth and Metastasis

  2006cites this paper
• Oral alveolar soft-part sarcoma: review of literature and case report with immunohistochemistry study for prognostic markers.

  2005cites this paper
• Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies

  2005influential citation
• Development of a Tissue Array for Primary Melanoma with Long-Term Follow-Up: Discovering Melanoma Cell Adhesion Molecule as an Important Prognostic Marker

  2005cites this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma.

  2005cites this paper
• Wild-Type p 53 and a p 53 Temperature-sensitive Mutant Suppress Human Soft Tissue Sarcoma by Enhancing Cell Cycle Control ’

  2005cites this paper
• p53 gene mutations in soft-tissue sarcomas-correlations with p53 immunohistochemistry and DNA ploidy

  2005cites this paper
• Peripheral Nervous System Tumors

  2004cites this paper
• Tissue microarray for immunostaining, the impor- tance of whole-tumor sections and time-dependence

  2004cites this paper
• Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67

  2004cites this paper
• Ki-67 expression in soft tissue sarcomas in children

  2004influential citation
• Analysis of the p53-hMDM2-p21 (WAF1/CIP1) Cell Cycle Regulation Pathway in Malignant Fibrous Histiocytomas.

  2004cites this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma.

  2004cites this paper
• Prognostic factors in soft tissue sarcomaTissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence

  2004cites this paper
• Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.

  2003cites this paper
• The Ki67 index a prognostic marker in medullary thyroid carcinoma

  2003influential citation
• Soft Tissue Sarcoma

  2003cites this paper
• p53 and mdm-2 Expression in Rhabdomyosarcoma of Childhood and Adolescence: Clinicopathologic Study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study

  2003cites this paper
• Transcriptomes of Soft Tissue Tumors

  2003cites this paper
• Soft tissue sarcomas of adults: state of the translational science.

  2003cites this paper
• Experimental approaches to treatment of soft tissue sarcoma.

  2003cites this paper
• Soft-Tissue Sarcomas

  2003cites this paper
• Expression of p53 and Proliferation Index as Prognostic Factors in Gastrointestinal Sarcomas

  2003cites this paper
• Radiation‐induced laryngeal angiosarcoma after cervical tuberculosis and squamous cell carcinoma: Case report and review of the literature

  2003cites this paper
• Staging and prognostic factor evaluation in soft tissue sarcoma.

  2003cites this paper
• Apoptosis and expression of its regulatory proteins in soft tissue sarcomas.

  2002cites this paper
• Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome.

  2002cites this paper
• Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases

  2002cites this paper
• Molecular Analysis of p53, MDM2, and H-ras Genes in Osteosarcoma and Malignant Fibrous Histiocytoma of Bone in Patients Older than 40 Years

  2002cites this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma.

  2002cites this paper
• Codon 12 and codon 13 mutations at the K‐ras gene induce different soft tissue sarcoma types in nude mice

  2002cites this paper
• p53 expression is a factor for prognostic assessment in breast sarcoma

  2002cites this paper
• Proliferative marker Ki-67 in gallbladder carcinomas: high expression level predicts early recurrence after surgical resection.

  2002cites this paper
• TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization

  2001cites this paper
• p53 protein expression and gene mutation in phyllodes tumors of the breast.

  2001cites this paper
• Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors.

  2001influential citation
• Malignant peripheral nerve sheath tumours: high Ki67 labelling index is the significant prognostic indicator

  2001cites this paper
• Tissue Microarray Technique in Soft Tissue Sarcoma: Immunohistochemical Ki-67 Expression in Malignant Fibrous Histiocytoma

  2001cites this paper
• Ki-67: a proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma.

  2001cites this paper
• Clinicopathologic analysis of patients with adult rhabdomyosarcoma

  2001cites this paper
• Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.

  2001cites this paper
• Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations

  2001cites this paper
• Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.

  2001cites this paper
• Grading in soft tissue tumors: principles and problems

  2001cites this paper
• Sclerosing Epithelioid Fibrosarcoma: A Study of 16 Cases and Confirmation of a Clinicopathologically Distinct Tumor

  2001cites this paper
• Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.

  2001cites this paper
• Low expression of p27Kip1, a cyclin‐dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma

  2001cites this paper
• Hypoxia in human intraperitoneal and extremity sarcomas.

  2001cites this paper
• Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

  2001cites this paper
• High Ki‐67 proliferative index predicts disease specific survival in patients with high‐risk soft tissue sarcomas

  2001cites this paper
• Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas.

  2001cites this paper
• Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down‐regulating multidrug resistance‐1 expression

  2001cites this paper
• Sclerosing Epithelioid Fibrosarcoma A Study of 16 Cases and Confirmation of a Clinicopathologically Distinct Tumor

  2001cites this paper
• (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.

  2000cites this paper
• Synovial sarcoma

  2000influential citation
• Alveolar soft part sarcoma: the role of prognostic markers.

  2000cites this paper
• Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma.

  2000cites this paper
• Prognostic Relevance of a Histological Grading System Using MIB-1 for Adult Soft-Tissue Sarcoma

  2000cites this paper
• Prognostic impact of P53 status in Ewing sarcoma

  2000cites this paper
• Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.

  2000cites this paper
• Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.

  2000cites this paper
• Cellular and Tissue Markers in Solid Tumors

  2000cites this paper
• [Soft tissue sarcoma: prognostic factors and multimodal treatment].

  2000cites this paper